Earnings Ahead

ABT - Abbott

125.4 0.11 0.09

Abbott

Abbott

About

Profile

We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to


Headquarters

Chicago, Illinois, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ABT



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Abbott Q2 results top consensus as base business offsets COVID impact
  • Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
  • Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
  • Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
  • Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
  • Goldman Sachs sees rays of hope in underperforming health sector
  • BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
  • FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
  • Medicare revises guidance on drug price negotiations amid lawsuits
  • Abbott gains expanded coverage for glucose monitoring device in France
  • Abbott names Philip Boudreau CFO effective Sept. 1
  • Abbott Laboratories declares $0.51 dividend
  • Abbott alleges former scientist in its nutrition unit stole trade secrets
  • Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
  • Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
  • Abbott boasts of heart failure reduction data for CardioMEMS device
  • Abbott, other baby-formula makers see FTC probe over collusion - report
  • Abbott recalled baby formula claims tossed by federal judge
  • Abbott gains approval of TactiFlex ablation catheter treatment
  • Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
Date Price Open High Low Vol Change
Dec 4 125.4 125.19
125.57
124.06
5.0M 0.09%
Dec 3 125.29 126.28
127.57
125.21
4.9M -0.82%
Dec 2 126.32 128.45
128.99
125.64
5.5M -1.32%
Dec 1 128.01 128.65
129.85
127.96
5.8M -0.69%
Nov 28 128.9 128.16
129.39
128
2.6M 0.28%
 
Nov 26 128.54 128.07
129.01
127.02
5.5M 0.38%
Nov 25 128.05 127.29
128.81
126.23
8.0M 0.68%
Nov 24 127.19 127.46
129.52
126.72
14.0M -0.72%
Nov 21 128.11 124.68
128.71
123.89
9.4M 3.34%
Nov 20 123.97 122.5
125.72
122.1
11.7M -1.73%
Nov 19 126.15 129.89
131.49
124.58
10.3M -2.96%
Nov 18 130 130.74
132.02
129.29
6.8M -0.02%
Nov 17 130.03 130.68
131.93
129.95
5.8M -0.43%
Nov 14 130.59 129.29
130.96
128.77
7.0M 1.03%
Nov 13 129.26 128.51
129.59
128
5.2M 0.34%
Nov 12 128.82 126.94
129.08
126.55
5.0M 1.43%
Nov 11 127 126.6
127.15
125.77
5.3M 0.88%
Nov 10 125.89 125.42
126.15
124.55
4.3M -0.37%
Nov 7 126.36 125.64
126.62
124.65
5.5M 1.13%
Nov 6 124.95 123.85
125
123.35
4.7M 0.33%
Nov 5 124.54 125.89
126.71
123.92
4.6M -1%
Nov 4 125.8 124.29
125.85
123.84
5.6M 1.58%
Nov 3 123.84 123.71
124.06
122.44
5.8M 0.18%
Oct 31 123.62 123.84
124.32
122.61
7.0M -0.84%
Oct 30 124.67 125.14
126.43
124.33
4.9M 0.19%
Oct 29 124.43 126.18
126.55
124.12
5.2M -1.72%
Oct 28 126.61 126.97
128.45
126.19
4.8M -0.45%
Oct 27 127.18 126.06
127.66
125.15
6.3M 0.26%
Oct 24 126.85 126.97
128.11
125
5.1M 0.40%
Oct 23 126.34 128.24
128.77
126.07
6.7M -1.26%
Oct 22 127.95 127.62
128.94
127.11
6.2M 0.32%
Oct 21 127.54 129
129.3
127.51
4.9M -1.52%
Oct 20 129.51 128.44
129.82
128.13
5.8M 0.75%
Oct 17 128.54 127.86
129.26
127.21
6.8M 0.71%
Oct 16 127.63 129.53
131.16
126.87
9.8M -1.41%
Oct 15 129.45 128.01
131.48
125.74
14.9M -2.87%
Oct 14 133.27 131.46
133.34
131.23
8.1M 1.44%
Oct 13 131.38 132
132.76
130.87
4.0M -0.9%
Oct 10 132.57 134.19
134.5
132.04
5.7M -0.56%
Oct 9 133.31 134.58
135.13
133
3.2M -0.71%
Oct 8 134.27 132.81
134.72
132.17
6.7M 0.94%
Oct 7 133.02 134.09
134.09
131.93
4.8M -0.54%
Oct 6 133.74 134.32
135.24
133.45
6.7M -0.63%
Oct 3 134.59 133.25
135.37
132.79
5.4M 1.20%
Oct 2 132.99 132.42
133.39
130.51
5.9M -0.36%
Oct 1 133.47 134.8
135.45
129.08
10.6M -0.35%
Sep 30 133.94 132.86
134.5
132.18
7.5M 0.62%
Sep 29 133.11 133
133.5
131.71
4.4M -0.33%
Sep 26 133.55 133.98
134.2
133.1
4.2M 0.18%
Sep 25 133.31 134.43
134.43
131.18
5.0M -0.43%
Sep 24 133.89 135.31
136.83
133.79
3.9M -1.47%
Sep 23 135.89 136.28
136.88
135.04
5.1M -0.53%
Sep 22 136.62 135.33
137.49
134.95
4.8M 0.43%
Sep 19 136.04 134.7
136.73
133.72
11.5M 1.09%
Sep 18 134.57 134.09
134.78
132.1
5.9M 0.30%
Sep 17 134.17 132.71
134.22
132.71
5.1M 1.06%
Sep 16 132.76 131.76
133.66
131.2
5.4M 1.09%
Sep 15 131.33 133.88
134.35
130.96
4.1M -1.79%
Sep 12 133.73 131.82
134.96
131.4
5.7M 0.81%
Sep 11 132.65 129.69
132.68
129.4
5.6M 0%